Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K A Harrison

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1995
SPECT imaging of fluorine-18P K Leichner, H T Morgan, K P Holdeman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1997
Patient-specific dosimetry of indium-111- and yttrium-90-labeled monoclonal antibody CC49P K Leichner, G Akabani, D Colcher, et al.
Journal of Lipid Research|April 6, 2001
Identification of platelet-activating factor as the inflammatory lipid mediator in CCl4-metabolizing rat liverG K Marathe, K A Harrison, L J Roberts, et al.
The Journal of Biological Chemistry|September 25, 1999
Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholinesG K Marathe, S S Davies, K A Harrison, et al.
The Journal of Biological Chemistry|March 30, 2001
Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonistsS S Davies, A V Pontsler, G K Marathe, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
On the safety of 5-[125I]iodo-2'-deoxyuridine--Preclinical evaluation in swineJ Baranowska-Kortylewicz, G V Dalrymple, K A Harrison, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1996
Radiolabeled iododeoxyuridine: safety evaluationK A Harrison, G V Dalrymple, J Baranowska-Kortylewicz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trialA N Serafini, S J Houston, I Resche, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1995
SPECT imaging of fluorine-18P K Leichner, H T Morgan, K P Holdeman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1997
Patient-specific dosimetry of indium-111- and yttrium-90-labeled monoclonal antibody CC49P K Leichner, G Akabani, D Colcher, et al.
Journal of Lipid Research|April 6, 2001
Identification of platelet-activating factor as the inflammatory lipid mediator in CCl4-metabolizing rat liverG K Marathe, K A Harrison, L J Roberts, et al.
The Journal of Biological Chemistry|September 25, 1999
Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholinesG K Marathe, S S Davies, K A Harrison, et al.
The Journal of Biological Chemistry|March 30, 2001
Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonistsS S Davies, A V Pontsler, G K Marathe, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
On the safety of 5-[125I]iodo-2'-deoxyuridine--Preclinical evaluation in swineJ Baranowska-Kortylewicz, G V Dalrymple, K A Harrison, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1996
Radiolabeled iododeoxyuridine: safety evaluationK A Harrison, G V Dalrymple, J Baranowska-Kortylewicz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trialA N Serafini, S J Houston, I Resche, et al.
Pageof 6